Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18588506rdf:typepubmed:Citationlld:pubmed
pubmed-article:18588506lifeskim:mentionsumls-concept:C0596290lld:lifeskim
pubmed-article:18588506lifeskim:mentionsumls-concept:C0079183lld:lifeskim
pubmed-article:18588506lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:18588506lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:18588506lifeskim:mentionsumls-concept:C0288590lld:lifeskim
pubmed-article:18588506lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:18588506lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:18588506pubmed:issue3lld:pubmed
pubmed-article:18588506pubmed:dateCreated2008-10-9lld:pubmed
pubmed-article:18588506pubmed:abstractTextIn the present study, we examined the role of PLC delta 1 (phospholipase C delta 1) in the regulation of cellular proliferation. We demonstrate that RNAi (RNA interference)-mediated knockdown of endogenous PLC delta 1, but not PLC beta 3 or PLC epsilon, induces a proliferation defect in Rat-1 and NIH 3T3 fibroblasts. The decreased proliferation was not due to an induction of apoptosis or senescence, but was associated with an approx. 60% inhibition of [(3)H]thymidine incorporation. Analysis of the cell cycle with BrdU (bromodeoxyuridine)/propidium iodide-labelled FACS (fluorescence-activated cell sorting) demonstrated an accumulation of cells in G(0)/G(1)-phase and a corresponding decrease in cells in S-phase. Further examination of the cell cycle after synchronization by serum-starvation demonstrated normal movement through G(1)-phase but delayed entry into S-phase. Consistent with these findings, G(1) cyclin (D2 and D3) and CDK4 (cyclin-dependent kinase 4) levels and associated kinase activity were not affected. However, cyclin E-associated CDK2 activity, responsible for G(1)-to-S-phase progression, was inhibited. This decreased activity was accompanied by unchanged CDK2 protein levels and paradoxically elevated cyclin E and cyclin E-associated CDK2 levels, suggesting inhibition of the cyclin E-CDK2 complex. This inhibition was not due to altered stimulatory or inhibitory phosphorylation of CDK2. However, p27, a Cip/Kip family CKI (CDK inhibitor)-binding partner, was elevated and showed increased association with CDK2 in PLC delta 1-knockdown cells. The result of the present study demonstrate a novel and critical role for PLC delta 1 in cell-cycle progression from G(1)-to-S-phase through regulation of cyclin E-CDK2 activity and p27 levels.lld:pubmed
pubmed-article:18588506pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18588506pubmed:languageenglld:pubmed
pubmed-article:18588506pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18588506pubmed:citationSubsetIMlld:pubmed
pubmed-article:18588506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18588506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18588506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18588506pubmed:statusMEDLINElld:pubmed
pubmed-article:18588506pubmed:monthNovlld:pubmed
pubmed-article:18588506pubmed:issn1470-8728lld:pubmed
pubmed-article:18588506pubmed:authorpubmed-author:ReksSarah ESElld:pubmed
pubmed-article:18588506pubmed:authorpubmed-author:KelleyGrant...lld:pubmed
pubmed-article:18588506pubmed:authorpubmed-author:LiXiangquanXlld:pubmed
pubmed-article:18588506pubmed:authorpubmed-author:Kaproth-Josli...lld:pubmed
pubmed-article:18588506pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18588506pubmed:day1lld:pubmed
pubmed-article:18588506pubmed:volume415lld:pubmed
pubmed-article:18588506pubmed:ownerNLMlld:pubmed
pubmed-article:18588506pubmed:authorsCompleteYlld:pubmed
pubmed-article:18588506pubmed:pagination439-48lld:pubmed
pubmed-article:18588506pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:meshHeadingpubmed-meshheading:18588506...lld:pubmed
pubmed-article:18588506pubmed:year2008lld:pubmed
pubmed-article:18588506pubmed:articleTitlePhospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.lld:pubmed
pubmed-article:18588506pubmed:affiliationDepartment of Medicine, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA.lld:pubmed
pubmed-article:18588506pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18588506pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18588506pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:18799entrezgene:pubmedpubmed-article:18588506lld:entrezgene